In addition to this identifying information, we proposed to require covered entities that choose to submit data to the 340B repository during the testing period beginning in 2026 to submit the following data elements from Part D claims for covered Part D drugs that are purchased under the 340B Program and dispensed to Medicare Part D beneficiaries: (1) Date of Service (that is, the date the prescription was filled by the pharmacy)
Features super doses of key immune-boosting vitamins such as Vitamin C, B complex, and Zinc, plus a high-dose Glutathione IV
A consultation and health assessment ensure safe dosing and proper infusion selection
[DOI] [PMC free article] [PubMed] [Google Scholar] 45.Mavromatis L.A., Surapaneni A., Mehta S., Xu Y., Chang A.R., Velcheti V., Ahn J., Shin J.-I., Grams M.E